NewsWireBroadcast.com  Wednesday, October 27, 1999  ===================================
  CancerOption.com (OTC BB: CAOP) announced that the Company will be holding a live on-line chat session with President and Chief Executive Officer, Arnold Takemoto.  The chat session will occur today at 3 p.m. EST.  All investors and interested parties are encouraged to join the chat session and post questions for Mr. Takemoto.  For full details on the chat session, we suggest you read the press release below.
  Furthermore, for a comprehensive research report on CancerOption.com, we suggest you visit AheadoftheStreet.com (AOTS).  AOTS began coverage of CancerOption.com at $3.50 at the end of September.  Since then, the stock has traded as high as $5.13, a 47% increase in only one month.  To read this research report on CancerOption.com and sign up for the Ahead Of The Street Newsletter, please visit: aheadofthestreet.com
  Should you have any questions with regards to CancerOption.com, we suggest you contact Corinne Wade of Investor Relations at (888) 320-6565 or via e-mail at caop@canceroption.com.
  ===================================  Company: CancerOption.com  Symbol: CAOP  Exchange: OTC:BB  Current Price: $5.00 ===================================
  PRESS RELEASE  For Immediate Release:  9:01am, October 27, 1999 
  CancerOption.com Invites the Public to Chat Live On-line With President and CEO, Arnold Takemoto 
  The Live Forum will Commence Today at 3pm EST / 12pm PST 
  CancerOption.com, Inc. (OTC BB: CAOP) is pleased to announce that President and Chief Executive Officer, Arnold Takemoto, will be hosting the Company's first on-line forum today at 3 p.m. EST / 12 p.m. PST. Individuals coping with cancer, along with cancer survivors, family members and visitors are invited to chat live on-line with Mr. Takemoto and ask questions about their unique situations. 
  Participants can start entering questions at 3 p.m. EST / 12 p.m. PST by visiting canceroption.com and clicking "Chat Rooms" on the main menu. The live forum will take place in the "Arnold Takemoto Chat" room and people can join the discussion anytime during the one-hour chat session. 
  About CancerOption.com CancerOption.com's mission is to provide a clear and concise informational stream of content in an effort to educate the general public and physicians on a variety of methods to enhance the immune system as it relates to cancer. Within the CancerOption.com virtual community, forums discussing the latest research findings, clinical trials, traditional and alternative therapies as well as professional forums with oncologists, physicians and health care professionals will be available worldwide. The protocols and targeted nutraceuticals, within the CancerOption.com portal, work in conjunction with current traditional cancer therapies. For additional information, visit us on-line at www.canceroption.com. 
  Contact: Investor Relations  Corinne Wade  Tel: (888) 320-6565 E-mail: caop@canceroption.com
  ===================================  This mailing has been sponsored by the company featured  or another party on behalf of the featured company. News  Wire Broadcast has been compensated for the  distribution of this e-mail. News Wire Broadcast provides this  service to public companies so as they can distribute news  releases and corporate profiles to individuals interested in  information small companies typically trading on the  OTCBB or NASDAQ exchanges. This is not an offer to  buy and sell any security which can only be made through  a registered representative. News Wire Broadcast makes  no warrantees as to the accuracy or completeness of  the above information.  Furthermore, AheadoftheStreet.com, a company owned and operated by the owner of News Wire Broadcast, has been compensated 14,100 free trading shares  of CancerOption.com by Thor Equity Group.
  Visit News Wire Broadcast at:  newswirebroadcast.com  ===================================  UNSUBSCRIBE  To unsubscribe, please e-mail: majordomo@bizfn.com  with the words: unsubscribe nwb  in the body of the e-mail message  |